- Management of patients with ATTR polyneuropathy
- Management of patients with ATTR cardiomyopathy
- Treatment of high-risk unfit patients with AL amyloidosis
- Treatment of fit patients with AL amyloidosis including ASCT
- Management of relapsed AL amyloidosis
Organ Transplantation in Systemic Amyloidosis
- Heart transplantation in AL amyloidosis
- Heart transplantation in ATTR amyloidosis
- Liver transplantation in hereditary ATTR amyloidosis
- Kidney transplant in AL amyloidosis and monoclonal immunoglobulin deposition disease: who and when?
Multidisciplinary Treatment Approach in the Management of Patients with AL Amyloidosis
- Diagnostic pit-falls and risk stratification in AL amyloidosis
(20 min + 10 min Q&A)
- Monoclonal antibody treatment for AL amyloidosis
(20 min + 10 min Q&A)
- Novel targets and drugs for AL amyloidosis
(20 min + 10 min Q&A)
International Kidney MG working Group
Autologous Stem-Cell Transplant in AL Amyloidosis:
Overview (14:00-14:20)
Question and Answer Panel (14:20-15:00)
- Patient selection
- Decreasing transplant-related mortality
- Pretransplant induction
- ASCT in patients with renal function impairment
- Any role for consolidation or maintenance?
- Is it time for CAR-T cell therapy in AL amyloidosis?
Hereditary Transthyretin Amyloidosis
- Multidisciplinary management and quality of life of patients with ATTR polyneuropathy
- Potential predictors of response and progression to treatment of hereditary TTR amyloidosis
- Treatment of hereditary TTR amyloidosis with antisense agents